stockportfolio.pro
Stocks / MASI vs PODD
MASI vs PODD
Masimo Corporation and Insulet Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
PODD is the larger company ($9.9B vs $9.4B). On the fundamentals, PODD grows revenue faster (24.5% vs 5.9%); PODD earns a higher net margin (9.1% vs -9.9%); PODD has the stronger return on equity (16.3% vs -21.0%). Full numbers below — the stronger figure on each row is in green.
| Masimo Corporation (MASI) | Insulet Corporation (PODD) | |
|---|---|---|
| Market cap | $9.4B | $9.9B |
| Revenue (latest FY) | $1.53B | $2.71B |
| Net income (latest FY) | $-151.50M | $247.10M |
| Revenue growth (5y CAGR) | 5.9% | 24.5% |
| Net margin | -9.9% | 9.1% |
| Return on equity | -21.0% | 16.3% |
| P/E ratio | 44.4 | 33.5 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 8 | 8 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full MASI vs PODD breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open MASI's full financials → Open PODD's full financials →More comparisons
Frequently asked questions
Which is bigger, MASI or PODD?
Insulet Corporation is larger by market capitalization — $9.9B versus $9.4B.
Which grows faster, MASI or PODD?
Over the last five fiscal years, Insulet Corporation grew revenue faster — 24.5%/yr versus 5.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.